HCPCS drug code · CMS crosswalk
Ketorolac Tromethamine J-Code / HCPCS Code
In short
Ketorolac Tromethamine is billed under HCPCS J1885 — Injection, ketorolac tromethamine, per 15 mg. One billing unit is 15 mg. CMS's crosswalk lists 71 Ketorolac Tromethamine NDCs under this code.
Reference
- J1885
- Injection, ketorolac tromethamine, per 15 mgBilling unit: 15 mg
- Labelers
- A-S Medication Solutions; Alembic Pharmaceuticals Inc.; Athenex Pharmaceutical Division, LLC; Baxter Healthcare Corporation; Caplin Steriles USA Inc.; Civica, Inc.; Fosun Pharma USA Inc.; FreseniUS Kabi USA, LLCand 8 more
Medicare Part B payment limit
CMS ASP filePayment limit per unit$0.569
Per15 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Ketorolac Tromethamine units and claim line
Enter the dose given to get the J1885 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Ketorolac Tromethamine NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00338-0069-10 | J1885 | Baxter Healthcare Corporation | 10 × 1 | 10 |
| 00338-0072-25 | J1885 | Baxter Healthcare Corporation | 25 × 1 | 50 |
| 00404-9952-01 | J1885 | Henry Schein Inc. | 1 | 1 |
| 00404-9996-01 | J1885 | Henry Schein Inc. | 1 | 2 |
| 00404-9997-02 | J1885 | Henry Schein Inc. | 2 | 4 |
| 00404-9998-01 | J1885 | Henry Schein Inc. | 1 | 1 |
| 00409-3793-01 | J1885 | Pfizer Inc | 25 × 1 | 25 |
| 00409-3793-25 | J1885 | Pfizer Inc | 25 × 1 | 25 |
| 00409-3795-01 | J1885 | Pfizer Inc | 25 × 1 | 50 |
| 00409-3795-25 | J1885 | Pfizer Inc | 25 × 1 | 50 |
| 00409-3796-01 | J1885 | Pfizer Inc | 25 × 2 | 100 |
| 00409-3796-25 | J1885 | Pfizer Inc | 25 × 2 | 100 |
| 00487-6232-01 | J1885 | Nephron SC, Inc. | 30 × 2 | 120 |
| 25021-0700-01 | J1885 | Sagent Pharmaceuticals | 25 × 1 | 25 |
| 25021-0701-01 | J1885 | Sagent Pharmaceuticals | 25 × 1 | 50 |
| 25021-0701-02 | J1885 | Sagent Pharmaceuticals | 25 × 2 | 100 |
| 50090-1328-01 | J1885 | A-S Medication Solutions | 2 | 4 |
| 50090-3364-00 | J1885 | A-S Medication Solutions | 25 × 1 | 50 |
| 50090-3364-01 | J1885 | A-S Medication Solutions | 25 × 1 | 50 |
| 50090-3397-01 | J1885 | A-S Medication Solutions | 25 × 2 | 100 |
| 50090-4583-00 | J1885 | A-S Medication Solutions | 25 × 2 | 100 |
| 50090-4635-00 | J1885 | A-S Medication Solutions | 25 × 2 | 100 |
| 50090-4635-01 | J1885 | A-S Medication Solutions | 2 | 4 |
| 50090-5013-00 | J1885 | A-S Medication Solutions | 25 × 1 | 50 |
| 50090-5013-01 | J1885 | A-S Medication Solutions | 1 | 2 |
| 50090-5428-00 | J1885 | A-S Medication Solutions | 25 × 1 | 50 |
| 50090-5428-01 | J1885 | A-S Medication Solutions | 1 | 2 |
| 50090-5609-00 | J1885 | A-S Medication Solutions | 25 × 1 | 25 |
| 50090-6772-00 | J1885 | A-S Medication Solutions | 25 × 2 | 100 |
| 50090-6772-01 | J1885 | A-S Medication Solutions | 2 | 4 |
| 50090-6807-00 | J1885 | A-S Medication Solutions | 25 × 1 | 25 |
| 51662-1292-01 | J1885 | HF Acquisition Co. LLC, DBA HealthFirst | 1 | 2 |
| 51662-1292-03 | J1885 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 1 | 50 |
| 51662-1295-01 | J1885 | HF Acquisition Co. LLC, DBA HealthFirst | 2 | 4 |
| 51662-1295-03 | J1885 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 2 | 100 |
| 51662-1594-03 | J1885 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 1 | 50 |
| 62332-0599-25 | J1885 | Alembic Pharmaceuticals Inc. | 25 × 1 | 25 |
| 62332-0600-25 | J1885 | Alembic Pharmaceuticals Inc. | 25 × 1 | 50 |
| 62332-0601-25 | J1885 | Alembic Pharmaceuticals Inc. | 25 × 2 | 100 |
| 63323-0161-01 | J1885 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| 63323-0161-12 | J1885 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| 63323-0161-16 | J1885 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| 63323-0162-01 | J1885 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| 63323-0162-02 | J1885 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| 63323-0162-12 | J1885 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| 63323-0162-14 | J1885 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| 63323-0162-16 | J1885 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| 63323-0162-26 | J1885 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| 65145-0145-25 | J1885 | Caplin Steriles USA Inc. | 25 × 1 | 50 |
| 65145-0146-25 | J1885 | Caplin Steriles USA Inc. | 25 × 1 | 25 |
| 65145-0147-25 | J1885 | Caplin Steriles USA Inc. | 25 × 2 | 100 |
| 68462-0755-25 | J1885 | Glenmark Pharmaceuticals Inc., USA | 25 × 1 | 25 |
| 68462-0756-25 | J1885 | Glenmark Pharmaceuticals Inc., USA | 25 × 1 | 50 |
| 68462-0757-25 | J1885 | Glenmark Pharmaceuticals Inc., USA | 25 × 2 | 100 |
| 70512-0842-25 | J1885 | Sola Pharmaceuticals | 25 × 1 | 25 |
| 70512-0843-25 | J1885 | Sola Pharmaceuticals | 25 × 1 | 50 |
| 70512-0844-25 | J1885 | Sola Pharmaceuticals | 25 × 2 | 100 |
| 70860-0700-02 | J1885 | Athenex Pharmaceutical Division, LLC | 25 × 1 | 25 |
| 70860-0701-03 | J1885 | Athenex Pharmaceutical Division, LLC | 25 × 1 | 50 |
| 70860-0701-04 | J1885 | Athenex Pharmaceutical Division, LLC | 25 × 2 | 100 |
| 72266-0118-25 | J1885 | Fosun Pharma USA Inc. | 25 × 1 | 50 |
| 72266-0119-25 | J1885 | Fosun Pharma USA Inc. | 25 × 2 | 100 |
| 72266-0234-25 | J1885 | Fosun Pharma USA Inc. | 25 × 1 | 25 |
| 72572-0354-10 | J1885 | Civica, Inc. | 10 × 1 | 10 |
| 72572-0355-25 | J1885 | Civica, Inc. | 25 × 1 | 50 |
| 72572-0356-25 | J1885 | Civica, Inc. | 25 × 1 | 25 |
| 72603-0153-25 | J1885 | Northstar RxLLC | 25 × 1 | 25 |
| 72603-0161-25 | J1885 | Northstar RxLLC | 25 × 1 | 50 |
| 76045-0104-10 | J1885 | FreseniUS Kabi USA, LLC | 24 × 1 | 48 |
| 76045-0105-20 | J1885 | FreseniUS Kabi USA, LLC | 24 × 2 | 96 |
| 76045-0209-10 | J1885 | FreseniUS Kabi USA, LLC | 24 × 1 | 48 |
Ketorolac Tromethamine: common questions
- What is the J-code for Ketorolac Tromethamine?
- Ketorolac Tromethamine is billed under HCPCS J1885 — Injection, ketorolac tromethamine, per 15 mg. One billing unit is 15 mg. CMS's crosswalk lists 71 Ketorolac Tromethamine NDCs under this code.
- How many J1885 billing units are in a package of Ketorolac Tromethamine?
- CMS lists 1 to 120 billing units per package, depending on the NDC, where one unit is 15 mg. Units to report are based on the dose given, not the package.
- Is J1885 a CPT code?
- No. J1885 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.